INTRODUCTION The use of topical mitomycin C (MMC) has gained popularity in the management of ocular surface neoplasia. The aim of this study is to determine outcomes and complications following such treatment. METHODS This study is a retrospective review of patients treated with topical MMC for ocular surface neoplasia, including primary acquired melanosis (PAM), melanoma, corneal-conjunctiva...

BACKGROUND This study was conducted to determine the treatment outcome of incompletely removed, histopathologically documented ocular surface squamous neoplasia with mitomycin-C. METHODS Through an interventional case series, 17 eyes of 17 patients presented with incompletely removed ocular surface squamous neoplasia were treated according to a protocol using two to three alternate seven-day ...

Gichuhi S, Macharia E, Kabiru J, et al. Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, doubleblind, placebo-controlled trial. Lancet Glob Health 2016; 4: e378–85— In this Article, the definition of CIN in table 1 should have read “CIN=conjunctival intra-epithelial neoplasia”. This correction has been made to the online version as of April 7, 2017.